Imagine trying to settle into a new home while constantly being attacked. That's what the bacterium Pseudomonas aeruginosa ...

Researchers at Intermountain Health have been awarded a $356,000 grant from Merck, a global science and technology company ...

The number of people that have been diagnosed with a pneumonia-causing bacteria has increased over the past six months. Older ...

Uptake of the pneumococcal and flu vaccines remain worryingly low among people with health conditions such as lung disease. Once bacterial pneumonia is diagnosed, antibiotic treatment should be ...

Most skin infections caused by bacteria, including methicillin-resistant staph aureus (MRSA), can be treated safely and effectively with an antibiotic. To get the best results from medicine used to ...

An international team of researchers has found that an antibiotic commonly prescribed for patients with liver disease, called rifaximin, has led to the global emergence of an almost untreatable form ...

Researchers from the University of Waterloo have developed a new technology that can hold an entire course of antibiotics in ...

The antibiotic, rifaximin, has enabled the global emergence of vancomycin-resistant enterococcus faecium, or VRE, a superbug ...

A small molecular strand could hold the key to solving one of the greatest global health challenges. When bacteria develop resistance to antibiotics, it can be deadly, but researchers have now decoded ...

Researchers from the University of Waterloo have developed a new technology that can hold an entire course of antibiotics in ...

Researchers have developed a new technology that can hold an entire course of antibiotics in one tiny dose and deliver on demand just the right amount of medication that a particular patient needs to ...

A new study has found that an antibiotic for liver disease patients could expose them to greater risk of a dangerous superbug.